Functional exosome-mediated co-delivery of doxorubicin and hydrophobically modified microRNA 159 for triple-negative breast cancer therapy
出版年份 2019 全文链接
标题
Functional exosome-mediated co-delivery of doxorubicin and hydrophobically modified microRNA 159 for triple-negative breast cancer therapy
作者
关键词
Exosome, MicroRNA 159, Doxorubicin, Triple-negative breast cancer, Co-delivery
出版物
JOURNAL OF NANOBIOTECHNOLOGY
Volume 17, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-09-03
DOI
10.1186/s12951-019-0526-7
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Exosome origin determines cell targeting and the transfer of therapeutic nanoparticles towards target cells
- (2019) María Sancho-Albero et al. JOURNAL OF NANOBIOTECHNOLOGY
- Exosomes in the tumor microenvironment as mediators of cancer therapy resistance
- (2019) Irene Li et al. Molecular Cancer
- New windows into the brain: Central nervous system-derived extracellular vesicles in blood
- (2019) Min Shi et al. PROGRESS IN NEUROBIOLOGY
- Injectable and protease-degradable hydrogel for siRNA sequestration and triggered delivery to the heart
- (2018) Leo L. Wang et al. JOURNAL OF CONTROLLED RELEASE
- Exosome-Mediated Small RNA Delivery: A Novel Therapeutic Approach for Inflammatory Lung Responses
- (2018) Duo Zhang et al. MOLECULAR THERAPY
- A33 antibody-functionalized exosomes for targeted delivery of doxorubicin against colorectal cancer
- (2018) Yan Li et al. Nanomedicine-Nanotechnology Biology and Medicine
- Exosome-Derived miR-130a Activates Angiogenesis in Gastric Cancer by Targeting C-MYB in Vascular Endothelial Cells
- (2018) Haiou Yang et al. MOLECULAR THERAPY
- Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication
- (2018) Mathilde Mathieu et al. NATURE CELL BIOLOGY
- Recent advancements in the use of exosomes as drug delivery systems
- (2018) Edwin J. Bunggulawa et al. JOURNAL OF NANOBIOTECHNOLOGY
- The roles of oncogenic miRNAs and their therapeutic importance in breast cancer
- (2017) Samia O'Bryan et al. EUROPEAN JOURNAL OF CANCER
- Co-delivery of autophagy inhibitor ATG7 siRNA and docetaxel for breast cancer treatment
- (2017) Chunai Gong et al. JOURNAL OF CONTROLLED RELEASE
- Curcumin Inhibits LIN-28A through the Activation of miRNA-98 in the Lung Cancer Cell Line A549
- (2017) Wei-Lun Liu et al. MOLECULES
- MicroRNA-377 suppresses initiation and progression of esophageal cancer by inhibiting CD133 and VEGF
- (2017) B Li et al. ONCOGENE
- Blood Exosomes Endowed with Magnetic and Targeting Properties for Cancer Therapy
- (2016) Hongzhao Qi et al. ACS Nano
- pH-sensitive nanocarrier based on gold/silver core–shell nanoparticles decorated multi-walled carbon manotubes for tracing drug release in living cells
- (2016) Peng Chen et al. BIOSENSORS & BIOELECTRONICS
- Epigenetic silencing of miR-490-3p promotes development of an aggressive colorectal cancer phenotype through activation of the Wnt/β-catenin signaling pathway
- (2016) Kehong Zheng et al. CANCER LETTERS
- Cross-kingdom inhibition of breast cancer growth by plant miR159
- (2016) Andrew R Chin et al. CELL RESEARCH
- Reducible self-assembling cationic polypeptide-based micelles mediate co-delivery of doxorubicin and microRNA-34a for androgen-independent prostate cancer therapy
- (2016) Chong Yao et al. JOURNAL OF CONTROLLED RELEASE
- Functional exosome-mimic for delivery of siRNA to cancer: in vitro and in vivo evaluation
- (2016) Zhaogang Yang et al. JOURNAL OF CONTROLLED RELEASE
- Exosome-mediated Delivery of Hydrophobically Modified siRNA for Huntingtin mRNA Silencing
- (2016) Marie-Cécile Didiot et al. MOLECULAR THERAPY
- Visualization of self-delivering hydrophobically modified siRNA cellular internalization
- (2016) Socheata Ly et al. NUCLEIC ACIDS RESEARCH
- Pygo2 activates MDR1 expression and mediates chemoresistance in breast cancer via the Wnt/β-catenin pathway
- (2016) Z-M Zhang et al. ONCOGENE
- Pharmacokinetics, biodistribution and cell uptake of antisense oligonucleotides
- (2015) Richard S. Geary et al. ADVANCED DRUG DELIVERY REVIEWS
- Phase II Study With Epirubicin, Cisplatin, and Infusional Fluorouracil Followed by Weekly Paclitaxel With Metronomic Cyclophosphamide as a Preoperative Treatment of Triple-Negative Breast Cancer
- (2015) Giuseppe Cancello et al. Clinical Breast Cancer
- Pathogenesis of pancreatic cancer exosome-induced lipolysis in adipose tissue
- (2015) Gunisha Sagar et al. GUT
- Defining a Role and Predicting Benefit From Platinum-Based Therapy in Breast Cancer: An Evolving Story
- (2015) Joseph A. Sparano JOURNAL OF CLINICAL ONCOLOGY
- Tumor-Infiltrating Lymphocytes and Response to Platinum in Triple-Negative Breast Cancer
- (2015) Nadine M. Tung et al. JOURNAL OF CLINICAL ONCOLOGY
- Breast-cancer-secreted miR-122 reprograms glucose metabolism in premetastatic niche to promote metastasis
- (2015) Miranda Y. Fong et al. NATURE CELL BIOLOGY
- Particle size distribution of exosomes and microvesicles determined by transmission electron microscopy, flow cytometry, nanoparticle tracking analysis, and resistive pulse sensing
- (2014) E. van der Pol et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Bioinspired Exosome-Mimetic Nanovesicles for Targeted Delivery of Chemotherapeutics to Malignant Tumors
- (2013) Su Chul Jang et al. ACS Nano
- Genetic Susceptibility to Triple-Negative Breast Cancer
- (2013) K. N. Stevens et al. CANCER RESEARCH
- Antigen-specific, antibody-coated, exosome-like nanovesicles deliver suppressor T-cell microRNA-150 to effector T cells to inhibit contact sensitivity
- (2013) Krzysztof Bryniarski et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Wnt signaling blockage inhibits cell proliferation and migration, and induces apoptosis in triple-negative breast cancer cells
- (2013) Birdal Bilir et al. Journal of Translational Medicine
- Estrogen Mediated-Activation of miR-191/425 Cluster Modulates Tumorigenicity of Breast Cancer Cells Depending on Estrogen Receptor Status
- (2013) Gianpiero Di Leva et al. PLoS Genetics
- Exosome release of ADAM15 and the functional implications of human macrophage-derived ADAM15 exosomes
- (2012) Hee Doo Lee et al. FASEB JOURNAL
- A translational study of urine miRNAs in acute myocardial infarction
- (2012) Yunhui Cheng et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- miR-221 Silencing Blocks Hepatocellular Carcinoma and Promotes Survival
- (2011) J.-K. Park et al. CANCER RESEARCH
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- Treatment of Brain Inflammatory Diseases by Delivering Exosome Encapsulated Anti-inflammatory Drugs From the Nasal Region to the Brain
- (2011) Xiaoying Zhuang et al. MOLECULAR THERAPY
- A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells
- (2011) Kim J. Png et al. NATURE
- Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes
- (2011) Lydia Alvarez-Erviti et al. NATURE BIOTECHNOLOGY
- FZD7 has a critical role in cell proliferation in triple negative breast cancer
- (2011) L Yang et al. ONCOGENE
- ADAM15 expression is downregulated in melanoma metastasis compared to primary melanoma
- (2010) Christopher Ungerer et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- ADAM15 to α5β1 integrin switch in colon carcinoma cells: A late event in cancer progression associated with tumor dedifferentiation and poor prognosis
- (2010) Claire Toquet et al. INTERNATIONAL JOURNAL OF CANCER
- Triple-Negative Breast Cancer
- (2010) William D. Foulkes et al. NEW ENGLAND JOURNAL OF MEDICINE
- ADAM15 suppresses cell motility by driving integrin α5β1 cell surface expression via Erk inactivation
- (2008) Qin Chen et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Distinct Functions of Natural ADAM-15 Cytoplasmic Domain Variants in Human Mammary Carcinoma
- (2008) J. L. Zhong et al. MOLECULAR CANCER RESEARCH
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started